Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Indolent T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Lymphoma
Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma by Clinical Course
Indolent Non-Hodgkin Lymphoma
Indolent T-Cell Non-Hodgkin Lymphoma

Hematologic Malignancy

Indolent T-Cell Non-Hodgkin Lymphoma

CI-CAN-00007850Explore in graph →

Hematologic33 active trials6 approved drugs

NCIt: C171300

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials134
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

134 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 33
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 15%
Top sponsor: City of Hope Medical Center
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

StatusAll Active (any)Completed 43 Recruiting 27 Terminated 22 Unknown 12 Not Yet Recruiting 9 Active Not Recruiting 9 Withdrawn 7 Suspended 5

PhaseAll Early Phase 1 4 N/A 9 Phase 1 41 Phase 2 57 Phase 3 5 Phase 4 6

No study matches these filters